Open AccessLiver injury after antiviral treatment of critically ill patients with COVID-19: a single-centered retrospective cohort study
Author(s) -
Xinjia Ruan,
Xiaofan Lu,
Kangyi Wang,
Bing Zhang,
Jun Wang,
Yongsheng Li,
Jiashuo Wang,
Zhengbao Xu,
Fangrong Yan
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-20-1581
Subject(s) - medicine , covid-19 , retrospective cohort study , critically ill , intensive care medicine , antiviral treatment , medline , cohort study , critical illness , cohort , emergency medicine , virology , disease , virus , chronic hepatitis , infectious disease (medical specialty) , law , outbreak , political science
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is the causative agent of coronavirus disease 2019 (COVID-19). Lung lesions are considered to be the main damage caused by SARSCoV-2 infection. In addition, liver injury has also been reported to occur during the course of the disease in severe cases. However, the effect of antiviral treatment on liver injury in critically ill patients is not yet clear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom